TMO

  
 
 
Thermo Fisher Scientific Inc.

Dividend Growth

Min. Div. Growth Past 7 Yrs. ≥ 15%: 15.2
Rolling 4-Yrs Div. Growth Past 7 Yrs ≥ 15%: 14.6%
Years of Div. Growth ≥ 15: 12

Income Generation

Current Yield 0.2≥ 20-Yrs Treasury Yield 4.0
Total Dividends ≥ 20-Yrs Treasury Coupons in 5 Yrs

Sustainability

Debt-To-Equity 0.43 ≤ 0.45 
Last 12Months Cash Payout 0.07 ≤ 0.6 

Profitability

5-Yr Avg. Return-on-Equity 16.5≥ 15%
Last 12Months Return-on-Equity 13.4≥ 15%
Last 12Months Net Profit Margin 14.7≥ 10% 

Fair Value

Average 5-Yrs High Yield 0.3%
Current Price $611.2 ≤ High Yield Price $500.2
Average 5-Yrs Price-to-Earning (P/E) 29.5
Current Price $611.2 ≤ Average P/E Price $475.8
Current Price $611.2 ≤ Fair Value $384.6 

Company Description
Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, protein detection assays, and instruments; immunodiagnostics develops, manufactures and markets complete bloodtest systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. It offers products and services through a direct sales force, customer-service professionals, electronic commerce, and third-party distributors under Thermo Scientific; Applied Biosystems; Invitrogen; Fisher Scientific; Unity Lab Services; and Patheon and PPD. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts.

Dividend

Revenue

Earning

Free Cash Flow